Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Tamm

Showing results (1-10 of 160) with videos related to

Pageof 16
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1977
Definition of subclasses of nucleoplasmic RNAI Tamm
Biochemical Pharmacology|February 15, 1984
HeLa cell RNA and protein syntheses. Effects of long-term treatment with 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB)I Tamm
New York State Journal of Medicine|June 1, 1979
Antiviral agents: prophylactic and therapeuticI Tamm
Virology|January 1, 1973
Kinetics and quantitative aspects of enhancement of influenza virus multiplication by 5-methyl-2-D-ribobenzimidazole (MRB)I Tamm
Das Offentliche Gesundheitswesen|February 1, 1990
[Decrease in tuberculosis mortality--a credit to medicine or sequela of an improved standard of living]I Tamm
The Journal of Experimental Medicine|October 1, 1973
Benzimidazole derivatives: new enhancers of influenza virus multiplicationI Tamm
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|February 1, 1974
Blocking of the virus-enhancing activity of 5-methyl-2-D-ribobenzimidazole (MRB)I Tamm
Annals of the New York Academy of Sciences|January 1, 1989
IL-6. Current research and new questionsI Tamm
The American Journal of Pathology|October 1, 1975
Cell injury with virusesI Tamm
Journal of Cellular Physiology|July 1, 1983
Recovery of HeLa cell population growth after treatment with 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB)I Tamm
Pageof 16

Showing results (1-10 of 160) with videos related to

Sort By:
Pageof 16
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1977
Definition of subclasses of nucleoplasmic RNAI Tamm
Biochemical Pharmacology|February 15, 1984
HeLa cell RNA and protein syntheses. Effects of long-term treatment with 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB)I Tamm
New York State Journal of Medicine|June 1, 1979
Antiviral agents: prophylactic and therapeuticI Tamm
Virology|January 1, 1973
Kinetics and quantitative aspects of enhancement of influenza virus multiplication by 5-methyl-2-D-ribobenzimidazole (MRB)I Tamm
Das Offentliche Gesundheitswesen|February 1, 1990
[Decrease in tuberculosis mortality--a credit to medicine or sequela of an improved standard of living]I Tamm
The Journal of Experimental Medicine|October 1, 1973
Benzimidazole derivatives: new enhancers of influenza virus multiplicationI Tamm
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|February 1, 1974
Blocking of the virus-enhancing activity of 5-methyl-2-D-ribobenzimidazole (MRB)I Tamm
Annals of the New York Academy of Sciences|January 1, 1989
IL-6. Current research and new questionsI Tamm
The American Journal of Pathology|October 1, 1975
Cell injury with virusesI Tamm
Journal of Cellular Physiology|July 1, 1983
Recovery of HeLa cell population growth after treatment with 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB)I Tamm
Pageof 16